News & Press ReleasesNews & Press ReleasesLatest Press Releases 27. May 2022Press ReleaseModra Pharmaceuticals Presents In-Depth Data Analysis from Lower Dose Cohort in Phase 2b Study of Oral Taxane ModraDoc006/r in mCRPC Patients at 2022 ASCO Annual MeetingRead More23. May 2022Press ReleaseModra Pharmaceuticals to Present New Phase 2b Data at the 2022 ASCO General Annual Meeting on ModraDoc006/r, a Boosted Oral Taxane for Patients with Metastatic Prostate CancerRead More17. February 2022Press ReleaseModra Pharmaceuticals Presents Positive Phase IIb Results for ModraDoc006/r, a Boosted Oral Taxane for Patients with Metastatic Prostate Cancer, at 2022 ASCO GU Annual MeetingRead More See all Press Releases Presentations Please find and download relevant company presentations here Company Presentation March 2021 Find out where to meet us. Our next Events
27. May 2022Press ReleaseModra Pharmaceuticals Presents In-Depth Data Analysis from Lower Dose Cohort in Phase 2b Study of Oral Taxane ModraDoc006/r in mCRPC Patients at 2022 ASCO Annual MeetingRead More
23. May 2022Press ReleaseModra Pharmaceuticals to Present New Phase 2b Data at the 2022 ASCO General Annual Meeting on ModraDoc006/r, a Boosted Oral Taxane for Patients with Metastatic Prostate CancerRead More
17. February 2022Press ReleaseModra Pharmaceuticals Presents Positive Phase IIb Results for ModraDoc006/r, a Boosted Oral Taxane for Patients with Metastatic Prostate Cancer, at 2022 ASCO GU Annual MeetingRead More